↓ Skip to main content

Rapid initial decline in BCR-ABL1 is associated with superior responses to second-line nilotinib in patients with chronic-phase chronic myeloid leukemia

Overview of attention for article published in BMC Cancer, April 2013
Altmetric Badge

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
21 Mendeley
citeulike
1 CiteULike